536 related articles for article (PubMed ID: 33227982)
1. Network Analysis of Gut Microbiome and Metabolome to Discover Microbiota-Linked Biomarkers in Patients Affected by Non-Small Cell Lung Cancer.
Vernocchi P; Gili T; Conte F; Del Chierico F; Conta G; Miccheli A; Botticelli A; Paci P; Caldarelli G; Nuti M; Marchetti P; Putignani L
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33227982
[TBL] [Abstract][Full Text] [Related]
2. The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti-Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC.
Jin Y; Dong H; Xia L; Yang Y; Zhu Y; Shen Y; Zheng H; Yao C; Wang Y; Lu S
J Thorac Oncol; 2019 Aug; 14(8):1378-1389. PubMed ID: 31026576
[TBL] [Abstract][Full Text] [Related]
3. Relationship between intestinal flora structure and metabolite analysis and immunotherapy efficacy in Chinese NSCLC patients.
Song P; Yang D; Wang H; Cui X; Si X; Zhang X; Zhang L
Thorac Cancer; 2020 Jun; 11(6):1621-1632. PubMed ID: 32329229
[TBL] [Abstract][Full Text] [Related]
4. Commensal microbiota contributes to predicting the response to immune checkpoint inhibitors in non-small-cell lung cancer patients.
Zhang C; Wang J; Sun Z; Cao Y; Mu Z; Ji X
Cancer Sci; 2021 Aug; 112(8):3005-3017. PubMed ID: 34028936
[TBL] [Abstract][Full Text] [Related]
5. Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment.
Botticelli A; Vernocchi P; Marini F; Quagliariello A; Cerbelli B; Reddel S; Del Chierico F; Di Pietro F; Giusti R; Tomassini A; Giampaoli O; Miccheli A; Zizzari IG; Nuti M; Putignani L; Marchetti P
J Transl Med; 2020 Feb; 18(1):49. PubMed ID: 32014010
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota and its metabolites in non-small cell lung cancer and brain metastasis: from alteration to potential microbial markers and drug targets.
Jiang H; Zeng W; Zhang X; Li Y; Wang Y; Peng A; Cao D
Front Cell Infect Microbiol; 2023; 13():1211855. PubMed ID: 38304459
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of gut, lung, and upper airways microbiota in patients with non-small cell lung carcinoma: Study protocol for case-control observational trial.
Bingula R; Filaire M; Radosevic-Robin N; Berthon JY; Bernalier-Donadille A; Vasson MP; Thivat E; Kwiatkowski F; Filaire E
Medicine (Baltimore); 2018 Dec; 97(50):e13676. PubMed ID: 30558074
[TBL] [Abstract][Full Text] [Related]
8. Microbiome-metabolomic analysis of the impact of Zizyphus jujuba cv. Muzao polysaccharides consumption on colorectal cancer mice fecal microbiota and metabolites.
Ji X; Hou C; Zhang X; Han L; Yin S; Peng Q; Wang M
Int J Biol Macromol; 2019 Jun; 131():1067-1076. PubMed ID: 30926487
[TBL] [Abstract][Full Text] [Related]
9. [Immuno-checkpoint inhibitor resistance and strategy in lung cancer].
Jiang WR; Fang LP; Chang N; Zhang J
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Jul; 43(7):603-606. PubMed ID: 32629564
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer-A review.
Nagasaka M; Sexton R; Alhasan R; Rahman S; Azmi AS; Sukari A
Crit Rev Oncol Hematol; 2020 Jan; 145():102841. PubMed ID: 31884204
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiome affects the response to immunotherapy in non-small cell lung cancer.
Ren S; Feng L; Liu H; Mao Y; Yu Z
Thorac Cancer; 2024 May; 15(14):1149-1163. PubMed ID: 38572783
[TBL] [Abstract][Full Text] [Related]
12. Impact of the microbiome on checkpoint inhibitor treatment in patients with non-small cell lung cancer and melanoma.
Shaikh FY; Gills JJ; Sears CL
EBioMedicine; 2019 Oct; 48():642-647. PubMed ID: 31597596
[TBL] [Abstract][Full Text] [Related]
13. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
[No Abstract] [Full Text] [Related]
14. Allergen Immunization Induces Major Changes in Microbiota Composition and Short-Chain Fatty Acid Production in Different Gut Segments in a Mouse Model of Lupine Food Allergy.
Andreassen M; Rudi K; Angell IL; Dirven H; Nygaard UC
Int Arch Allergy Immunol; 2018; 177(4):311-323. PubMed ID: 30244242
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiota in Lung Cancer: Where Do We Stand?
Georgiou K; Marinov B; Farooqi AA; Gazouli M
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638770
[TBL] [Abstract][Full Text] [Related]
16. Interaction of bacterial genera associated with therapeutic response to immune checkpoint PD-1 blockade in a United States cohort.
Newsome RC; Gharaibeh RZ; Pierce CM; da Silva WV; Paul S; Hogue SR; Yu Q; Antonia S; Conejo-Garcia JR; Robinson LA; Jobin C
Genome Med; 2022 Mar; 14(1):35. PubMed ID: 35346337
[TBL] [Abstract][Full Text] [Related]
17. Integrated microbiome, metabolome, and proteome analysis identifies a novel interplay among commensal bacteria, metabolites and candidate targets in non-small cell lung cancer.
Qian X; Zhang HY; Li QL; Ma GJ; Chen Z; Ji XM; Li CY; Zhang AQ
Clin Transl Med; 2022 Jun; 12(6):e947. PubMed ID: 35735103
[TBL] [Abstract][Full Text] [Related]
18. Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer.
Manjarrez-Orduño N; Menard LC; Kansal S; Fischer P; Kakrecha B; Jiang C; Cunningham M; Greenawalt D; Patel V; Yang M; Golhar R; Carman JA; Lezhnin S; Dai H; Kayne PS; Suchard SJ; Bernstein SH; Nadler SG
Front Immunol; 2018; 9():1613. PubMed ID: 30123214
[TBL] [Abstract][Full Text] [Related]
19. Predictive biomarkers of response for immune checkpoint inhibitors in non-small-cell lung cancer.
Prelaj A; Tay R; Ferrara R; Chaput N; Besse B; Califano R
Eur J Cancer; 2019 Jan; 106():144-159. PubMed ID: 30528799
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC).
Jeanson A; Tomasini P; Souquet-Bressand M; Brandone N; Boucekine M; Grangeon M; Chaleat S; Khobta N; Milia J; Mhanna L; Greillier L; Biemar J; Nanni I; Ouafik L; Garcia S; Mazières J; Barlesi F; Mascaux C
J Thorac Oncol; 2019 Jun; 14(6):1095-1101. PubMed ID: 30738221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
